In addition, targeting genes upregulated under hypoxia in our study, such as prolyl 4-hydroxylase subunit alpha 1 (P4HA1), promoted T cell memory and enhanced their systemic anti-cancer immunity [59], further highlighting the potential of our model for future therapeutic discovery. This evidence concerns the gene P4HA1 and cancer.